Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Neil Stahl. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Neil Stahl zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:REGN / Regeneron Pharmaceuticals, Inc. | EVP Research and Development | 48 829 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Neil Stahl. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Neil Stahl ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -304 | 48 829 | -0,62 | 730,81 | -222 166 | 35 684 721 | |
| 2024-12-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -466 | 49 133 | -0,94 | 787,00 | -366 742 | 38 667 671 | |
| 2024-08-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | -500 | 49 599 | -1,00 | ||||
| 2024-08-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | -900 | 50 099 | -1,76 | ||||
| 2024-08-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -300 | 50 999 | -0,58 | 1 086,15 | -325 845 | 55 392 564 | |
| 2024-08-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 708 | 51 299 | -3,22 | 1 085,01 | -1 853 197 | 55 659 928 | |
| 2024-08-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 883 | 53 007 | -3,43 | 1 084,61 | -2 042 321 | 57 491 922 | |
| 2024-08-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 006 | 54 890 | -1,80 | 1 083,76 | -1 090 263 | 59 487 586 | |
| 2024-08-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -200 | 55 896 | -0,36 | 1 082,69 | -216 538 | 60 518 040 | |
| 2024-08-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -100 | 56 096 | -0,18 | 1 081,83 | -108 183 | 60 686 336 | |
| 2024-08-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -18 441 | 56 196 | -24,71 | 1 093,49 | -20 165 049 | 61 449 764 | |
| 2024-08-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 23 638 | 74 637 | 46,35 | 555,67 | 13 134 927 | 41 473 542 | |
| 2024-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | -1 020 | 50 999 | -1,96 | ||||
| 2024-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -19 | 52 019 | -0,04 | 953,00 | -18 107 | 49 574 107 | |
| 2024-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 059 | 52 038 | -1,99 | 952,49 | -1 008 687 | 49 565 675 | |
| 2024-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 237 | 53 097 | -2,28 | 951,49 | -1 176 993 | 50 521 265 | |
| 2024-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -3 127 | 54 334 | -5,44 | 950,43 | -2 971 995 | 51 640 664 | |
| 2024-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -601 | 57 461 | -1,04 | 949,45 | -570 619 | 54 556 346 | |
| 2024-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 894 | 58 062 | -3,16 | 948,69 | -1 796 819 | 55 082 839 | |
| 2024-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -100 | 59 956 | -0,17 | 947,34 | -94 734 | 56 798 717 | |
| 2024-02-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -22 713 | 60 056 | -27,44 | 956,65 | -21 728 391 | 57 452 572 | |
| 2024-02-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 30 750 | 82 769 | 59,11 | 399,66 | 12 289 545 | 33 079 459 | |
| 2023-12-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -725 | 52 019 | -1,37 | 844,09 | -611 965 | 43 908 718 | |
| 2023-12-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 853 | 52 744 | 1,64 | ||||
| 2023-12-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -809 | 51 891 | -1,54 | 843,79 | -682 626 | 43 785 107 | |
| 2023-11-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | -400 | 52 700 | -0,75 | ||||
| 2023-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -782 | 53 100 | -1,45 | 842,16 | -658 569 | 44 718 696 | |
| 2023-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -4 574 | 53 882 | -7,82 | 841,41 | -3 848 609 | 45 336 854 | |
| 2023-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -6 309 | 58 456 | -9,74 | 840,53 | -5 302 904 | 49 134 022 | |
| 2023-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -38 335 | 64 765 | -37,18 | 833,39 | -31 948 006 | 53 974 503 | |
| 2023-08-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 50 000 | 103 100 | 94,16 | 399,66 | 19 983 000 | 41 204 946 | |
| 2022-12-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1 101 | 53 100 | 2,12 | ||||
| 2022-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -466 | 51 999 | -0,89 | 753,28 | -351 028 | 39 169 807 | |
| 2022-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | -330 | 52 465 | -0,63 | ||||
| 2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -100 | 52 795 | -0,19 | 621,11 | -62 111 | 32 791 502 | |
| 2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -177 | 52 895 | -0,33 | 620,11 | -109 759 | 32 800 718 | |
| 2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -502 | 53 072 | -0,94 | 619,64 | -311 059 | 32 885 534 | |
| 2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -521 | 53 574 | -0,96 | 618,27 | -322 119 | 33 123 197 | |
| 2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -424 | 54 095 | -0,78 | 617,43 | -261 790 | 33 399 876 | |
| 2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -535 | 54 519 | -0,97 | 616,40 | -329 774 | 33 605 512 | |
| 2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 610 | 55 054 | -2,84 | 615,49 | -990 939 | 33 885 186 | |
| 2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -4 112 | 56 664 | -6,77 | 614,35 | -2 526 207 | 34 811 528 | |
| 2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -3 218 | 60 776 | -5,03 | 613,49 | -1 974 211 | 37 285 468 | |
| 2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2 076 | 63 994 | -3,14 | 612,43 | -1 271 405 | 39 191 845 | |
| 2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2 022 | 66 070 | -2,97 | 611,44 | -1 236 332 | 40 397 841 | |
| 2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -3 931 | 68 092 | -5,46 | 610,49 | -2 399 836 | 41 569 485 | |
| 2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -3 044 | 72 023 | -4,06 | 609,62 | -1 855 683 | 43 906 661 | |
| 2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -610 | 75 067 | -0,81 | 608,70 | -371 307 | 45 693 283 | |
| 2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -724 | 75 677 | -0,95 | 607,47 | -439 808 | 45 971 507 | |
| 2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -176 | 76 401 | -0,23 | 606,78 | -106 793 | 46 358 599 | |
| 2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -71 218 | 76 577 | -48,19 | 613,00 | -43 656 634 | 46 941 701 | |
| 2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 95 000 | 147 795 | 179,94 | 270,43 | 25 690 850 | 39 968 202 | |
| 2022-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | -335 | 52 795 | -0,63 | ||||
| 2021-12-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -753 | 53 130 | -1,40 | 664,34 | -500 248 | 35 296 384 | |
| 2021-12-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 12 494 | 12 494 | |||||
| 2021-12-10 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2 926 | 53 883 | 5,74 | ||||
| 2021-12-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -72 500 | 0 | -100,00 | ||||
| 2021-12-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -50 352 | 50 957 | -49,70 | 632,45 | -31 845 122 | 32 227 755 | |
| 2021-12-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 72 500 | 101 309 | 251,66 | 179,13 | 12 986 925 | 18 147 481 | |
| 2021-12-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | 4 605 | 4 605 | |||||
| 2021-12-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | -4 605 | 28 809 | -13,78 | ||||
| 2021-05-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -3 806 | 24 280 | -13,55 | 520,17 | -1 979 767 | 12 629 728 | |
| 2021-05-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -10 336 | 28 086 | -26,90 | 519,47 | -5 369 242 | 14 589 834 | |
| 2021-05-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -3 379 | 38 422 | -8,08 | 518,63 | -1 752 451 | 19 926 802 | |
| 2021-05-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -40 000 | 72 500 | -35,56 | ||||
| 2021-05-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -12 500 | 0 | -100,00 | ||||
| 2021-05-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -7 204 | 41 801 | -14,70 | 516,69 | -3 722 235 | 21 598 159 | |
| 2021-05-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 12 500 | 49 005 | 34,24 | 52,03 | 650 375 | 2 549 730 | |
| 2021-05-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -27 775 | 36 505 | -43,21 | 516,69 | -14 351 065 | 18 861 768 | |
| 2021-05-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 40 000 | 64 280 | 164,74 | 179,13 | 7 165 200 | 11 514 476 | |
| 2021-05-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | -435 | 24 280 | -1,76 | ||||
| 2020-12-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 17 500 | 17 500 | |||||
| 2020-12-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1 688 | 24 715 | 7,33 | ||||
| 2020-12-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | -750 | 20 979 | -3,45 | ||||
| 2020-05-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2 026 | 11 380 | -15,11 | 570,28 | -1 155 387 | 6 489 786 | |
| 2020-05-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2 175 | 13 406 | -13,96 | 569,39 | -1 238 423 | 7 633 242 | |
| 2020-05-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -792 | 15 581 | -4,84 | 568,71 | -450 418 | 8 861 071 | |
| 2020-05-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -312 | 16 373 | -1,87 | 567,50 | -177 060 | 9 291 678 | |
| 2020-05-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -12 500 | 12 500 | -50,00 | ||||
| 2020-05-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -7 195 | 16 685 | -30,13 | 560,67 | -4 034 021 | 9 354 779 | |
| 2020-05-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 12 500 | 23 880 | 109,84 | 52,03 | 650 375 | 1 242 476 | |
| 2020-04-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -357 | 11 380 | -3,04 | 524,26 | -187 161 | 5 966 079 |
| 2020-04-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -758 | 11 737 | -6,07 | 522,37 | -395 956 | 6 131 057 |
| 2020-04-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -1 595 | 12 495 | -11,32 | 521,32 | -831 505 | 6 513 893 |
| 2020-04-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -2 096 | 14 090 | -12,95 | 520,43 | -1 090 821 | 7 332 859 |
| 2020-04-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -422 | 16 186 | -2,54 | 519,85 | -219 377 | 8 414 292 |
| 2020-04-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -267 | 16 608 | -1,58 | 518,54 | -138 450 | 8 611 912 |
| 2020-04-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -2 | 16 875 | -0,01 | 517,99 | -1 036 | 8 741 081 |
| 2020-04-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -13 079 | 25 000 | -34,35 | |||
| 2020-04-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | X | -7 582 | 16 877 | -31,00 | 511,56 | -3 878 648 | 8 633 598 |
| 2020-04-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 13 079 | 24 459 | 114,93 | 52,03 | 680 500 | 1 272 602 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -25 000 | 38 079 | -39,63 | |||
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -31 | 11 380 | -0,27 | 468,56 | -14 525 | 5 332 213 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -227 | 11 411 | -1,95 | 465,42 | -105 650 | 5 310 908 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -126 | 11 638 | -1,07 | 464,14 | -58 482 | 5 401 661 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -123 | 11 764 | -1,03 | 463,10 | -56 961 | 5 447 908 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -1 | 11 887 | -0,01 | 462,15 | -462 | 5 493 577 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -614 | 11 888 | -4,91 | 461,24 | -283 201 | 5 483 221 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -252 | 12 502 | -1,98 | 460,34 | -116 006 | 5 755 171 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -692 | 12 754 | -5,15 | 459,47 | -317 953 | 5 860 080 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -460 | 13 446 | -3,31 | 458,59 | -210 951 | 6 166 201 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -141 | 13 906 | -1,00 | 457,27 | -64 475 | 6 358 797 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -743 | 14 047 | -5,02 | 456,63 | -339 276 | 6 414 282 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -2 967 | 14 790 | -16,71 | 455,56 | -1 351 647 | 6 737 732 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -102 | 17 757 | -0,57 | 454,58 | -46 367 | 8 071 977 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -113 | 17 859 | -0,63 | 453,45 | -51 240 | 8 098 164 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -130 | 17 972 | -0,72 | 452,08 | -58 770 | 8 124 782 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -233 | 18 102 | -1,27 | 451,47 | -105 193 | 8 172 510 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -125 | 18 335 | -0,68 | 450,10 | -56 262 | 8 252 584 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -236 | 18 460 | -1,26 | 449,53 | -106 089 | 8 298 324 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -240 | 18 696 | -1,27 | 448,86 | -107 726 | 8 391 887 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -120 | 18 936 | -0,63 | 445,91 | -53 509 | 8 443 752 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -490 | 19 056 | -2,51 | 444,65 | -217 878 | 8 473 250 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -264 | 19 546 | -1,33 | 443,67 | -117 129 | 8 671 974 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -395 | 19 810 | -1,95 | 440,24 | -173 895 | 8 721 154 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -231 | 20 205 | -1,13 | 439,73 | -101 578 | 8 884 745 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -256 | 20 436 | -1,24 | 438,63 | -112 289 | 8 963 843 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -480 | 20 692 | -2,27 | 437,41 | -209 957 | 9 050 888 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -348 | 21 172 | -1,62 | 436,43 | -151 878 | 9 240 096 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -209 | 21 520 | -0,96 | 435,93 | -91 109 | 9 381 214 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | X | -14 651 | 21 729 | -40,27 | 451,89 | -6 620 640 | 9 819 118 |
| 2020-02-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 25 000 | 36 380 | 219,68 | 52,03 | 1 300 750 | 1 892 851 |
| 2020-02-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -31 | 11 380 | -0,27 | 406,44 | -12 600 | 4 625 287 |
| 2020-02-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -1 279 | 11 411 | -10,08 | 402,35 | -514 606 | 4 591 216 |
| 2020-02-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -2 058 | 12 690 | -13,95 | 401,46 | -826 205 | 5 094 527 |
| 2020-02-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -2 608 | 14 748 | -15,03 | 400,54 | -1 044 608 | 5 907 164 |
| 2020-02-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | -4 302 | 17 356 | -19,86 | 399,80 | -1 719 940 | 6 938 929 |
| 2020-02-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -25 000 | 63 079 | -28,38 | |||
| 2020-02-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | X | -14 722 | 21 658 | -40,47 | 402,34 | -5 923 249 | 8 713 880 |
| 2020-02-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 25 000 | 36 380 | 219,68 | 52,03 | 1 300 750 | 1 892 851 |
| 2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 24 500 | 24 500 | |||||
| 2019-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2 625 | 11 380 | 29,98 | ||||
| 2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -300 | 22 455 | -1,32 | 365,41 | -109 623 | 8 205 282 | |
| 2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2 284 | 22 755 | -9,12 | 364,20 | -831 833 | 8 287 371 | |
| 2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 422 | 25 039 | -5,37 | 363,58 | -517 011 | 9 103 680 | |
| 2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -10 000 | 88 079 | -10,20 | ||||
| 2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | -5 994 | 26 461 | -18,47 | 362,75 | -2 174 324 | 9 598 728 | |
| 2019-11-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 10 000 | 32 455 | 44,53 | 52,03 | 520 300 | 1 688 634 | |
| 2019-11-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -300 | 22 455 | -1,32 | 341,38 | -102 414 | 7 665 688 | |
| 2019-11-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2 064 | 22 755 | -8,32 | 340,48 | -702 751 | 7 747 622 | |
| 2019-11-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 100 | 24 819 | -4,24 | 339,53 | -373 483 | 8 426 795 | |
| 2019-11-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 100 | 25 919 | -4,07 | 338,54 | -372 394 | 8 774 618 | |
| 2019-11-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1 500 | 27 019 | -5,26 | 337,41 | -506 115 | 9 116 481 | |
| 2019-11-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -500 | 28 519 | -1,72 | 336,73 | -168 365 | 9 603 203 | |
| 2019-11-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -400 | 29 019 | -1,36 | 335,45 | -134 180 | 9 734 424 | |
| 2019-11-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -100 | 29 419 | -0,34 | 334,66 | -33 466 | 9 845 363 | |
| 2019-11-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -200 | 29 519 | -0,67 | 333,32 | -66 664 | 9 839 273 | |
| 2019-11-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -100 | 29 719 | -0,34 | 330,56 | -33 056 | 9 823 913 | |
| 2019-11-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
G - Gift | -1 300 | 21 150 | -5,79 | ||||
| 2019-05-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -3 278 | 22 450 | -12,74 | 306,37 | -1 004 281 | 6 878 006 | |
| 2019-05-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -6 575 | 25 728 | -20,35 | 305,43 | -2 008 202 | 7 858 103 | |
| 2019-05-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -25 000 | 98 079 | -20,31 | ||||
| 2019-05-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -15 147 | 32 303 | -31,92 | 304,20 | -4 607 717 | 9 826 573 | |
| 2019-05-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 25 000 | 47 450 | 111,36 | 52,03 | 1 300 750 | 2 468 824 | |
| 2018-12-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | |||||
| 2018-05-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -11 407 | 31 973 | -26,30 | 295,09 | -3 366 092 | 9 434 913 | |
| 2018-05-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -26 736 | 0 | -100,00 | ||||
| 2018-05-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -15 329 | 43 380 | -26,11 | 293,68 | -4 501 821 | 12 739 838 | |
| 2018-05-25 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 26 736 | 58 709 | 83,62 | 30,63 | 818 924 | 1 798 257 | |
| 2017-12-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 50 000 | 50 000 | |||||
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -100 | 23 950 | -0,42 | 541,70 | -54 170 | 12 973 715 |
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -100 | 24 050 | -0,41 | 540,04 | -54 004 | 12 987 962 |
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -200 | 24 150 | -0,82 | 539,36 | -107 872 | 13 025 544 |
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -600 | 24 350 | -2,40 | 538,39 | -323 034 | 13 109 796 |
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -200 | 24 950 | -0,80 | 537,42 | -107 484 | 13 408 629 |
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -800 | 25 150 | -3,08 | 536,46 | -429 168 | 13 491 969 |
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -800 | 25 950 | -2,99 | 535,37 | -428 296 | 13 892 852 |
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -700 | 26 750 | -2,55 | 534,64 | -374 248 | 14 301 620 |
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -905 | 27 450 | -3,19 | 533,49 | -482 808 | 14 644 300 |
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -500 | 28 355 | -1,73 | 532,44 | -266 220 | 15 097 336 |
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -900 | 28 855 | -3,02 | 531,42 | -478 278 | 15 334 124 |
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -800 | 29 755 | -2,62 | 530,64 | -424 512 | 15 789 193 |
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -100 | 30 555 | -0,33 | 529,61 | -52 961 | 16 182 234 |
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -600 | 30 655 | -1,92 | 526,45 | -315 870 | 16 138 325 |
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -400 | 31 255 | -1,26 | 525,10 | -210 040 | 16 412 000 |
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -101 | 31 655 | -0,32 | 524,08 | -52 932 | 16 589 752 |
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -200 | 31 756 | -0,63 | 523,52 | -104 704 | 16 624 901 |
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -200 | 31 956 | -0,62 | 522,80 | -104 560 | 16 706 597 |
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -100 | 32 156 | -0,31 | 521,70 | -52 170 | 16 775 785 |
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -20 000 | 26 736 | -42,79 | |||
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | -10 493 | 32 256 | -24,55 | 510,02 | -5 351 640 | 16 451 205 |
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | -1 201 | 42 749 | -2,73 | 510,02 | -612 534 | 21 802 845 |
| 2017-06-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 20 000 | 43 950 | 83,51 | 30,63 | 612 600 | 1 346 188 |
| 2017-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -100 | 23 950 | -0,42 | 474,48 | -47 448 | 11 363 796 |
| 2017-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -100 | 24 050 | -0,41 | 472,95 | -47 295 | 11 374 448 |
| 2017-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -100 | 24 150 | -0,41 | 471,15 | -47 115 | 11 378 272 |
| 2017-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 426 | 24 250 | -9,09 | 470,57 | -1 141 603 | 11 411 322 |
| 2017-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 212 | 26 676 | -7,66 | 469,53 | -1 038 600 | 12 525 182 |
| 2017-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -900 | 28 888 | -3,02 | 468,63 | -421 767 | 13 537 783 |
| 2017-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -300 | 29 788 | -1,00 | 467,82 | -140 346 | 13 935 422 |
| 2017-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -185 | 30 088 | -0,61 | 466,52 | -86 306 | 14 036 654 |
| 2017-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 244 | 30 273 | -3,95 | 465,49 | -579 070 | 14 091 779 |
| 2017-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -400 | 31 517 | -1,25 | 464,69 | -185 876 | 14 645 635 |
| 2017-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -100 | 31 917 | -0,31 | 463,91 | -46 391 | 14 806 615 |
| 2017-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -500 | 32 017 | -1,54 | 462,72 | -231 360 | 14 814 906 |
| 2017-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -20 295 | 0 | -100,00 | |||
| 2017-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | -10 822 | 32 517 | -24,97 | 475,56 | -5 146 510 | 15 463 785 |
| 2017-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | -906 | 43 339 | -2,05 | 475,56 | -430 857 | 20 610 295 |
| 2017-06-16 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 20 295 | 44 245 | 84,74 | 21,25 | 431 269 | 940 206 |
| 2017-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -200 | 23 950 | -0,83 | 483,42 | -96 684 | 11 577 909 |
| 2017-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -808 | 24 150 | -3,24 | 482,56 | -389 908 | 11 653 824 |
| 2017-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -695 | 24 958 | -2,71 | 481,64 | -334 740 | 12 020 771 |
| 2017-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -309 | 25 653 | -1,19 | 480,71 | -148 539 | 12 331 654 |
| 2017-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -100 | 25 962 | -0,38 | 479,00 | -47 900 | 12 435 798 |
| 2017-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -100 | 26 062 | -0,38 | 476,52 | -47 652 | 12 419 064 |
| 2017-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -100 | 26 162 | -0,38 | 475,33 | -47 533 | 12 435 583 |
| 2017-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -100 | 26 262 | -0,38 | 474,82 | -47 482 | 12 469 723 |
| 2017-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -100 | 26 362 | -0,38 | 472,10 | -47 210 | 12 445 500 |
| 2017-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -100 | 26 462 | -0,38 | 470,49 | -47 049 | 12 450 106 |
| 2017-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -100 | 26 562 | -0,38 | 469,83 | -46 983 | 12 479 624 |
| 2017-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -100 | 26 662 | -0,37 | 466,33 | -46 633 | 12 433 290 |
| 2017-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -4 527 | 0 | -100,00 | |||
| 2017-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -6 017 | 0 | -100,00 | |||
| 2017-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | -2 167 | 26 762 | -7,49 | 464,98 | -1 007 612 | 12 443 795 |
| 2017-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | -1 885 | 28 929 | -6,12 | 464,98 | -876 487 | 13 451 406 |
| 2017-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 017 | 30 814 | 24,27 | 145,70 | 876 677 | 4 489 600 |
| 2017-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | -1 068 | 24 797 | -4,13 | 464,98 | -496 599 | 11 530 109 |
| 2017-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | -2 612 | 25 865 | -9,17 | 464,98 | -1 214 528 | 12 026 708 |
| 2017-06-05 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 527 | 28 477 | 18,90 | 268,40 | 1 215 047 | 7 643 227 |
| 2016-12-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 58 342 | 58 342 | |||||
| 2016-12-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | -7 876 | 23 950 | -24,75 | ||||
| 2016-12-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | -1 500 | 40 470 | -3,57 | ||||
| 2015-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 68 638 | 68 638 | |||||
| 2015-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | -1 921 | 0 | -100,00 | ||||
| 2015-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 921 | 27 594 | 7,48 | 52,03 | 99 950 | 1 435 716 | |
| 2015-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -900 | 22 029 | -3,93 | 563,41 | -507 069 | 12 411 359 | |
| 2015-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -5 607 | 22 929 | -19,65 | 562,31 | -3 152 872 | 12 893 206 | |
| 2015-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -500 | 28 536 | -1,72 | 561,36 | -280 680 | 16 018 969 | |
| 2015-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -3 900 | 29 036 | -11,84 | 560,31 | -2 185 209 | 16 269 161 | |
| 2015-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 500 | 32 936 | -4,36 | 559,26 | -838 890 | 18 419 787 | |
| 2015-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -9 694 | 34 436 | -21,97 | 558,37 | -5 412 839 | 19 228 029 | |
| 2015-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -2 100 | 44 130 | -4,54 | 564,19 | -1 184 799 | 24 897 705 | |
| 2015-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -8 345 | 46 230 | -15,29 | 563,43 | -4 701 823 | 26 047 369 | |
| 2015-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -9 555 | 54 575 | -14,90 | 562,37 | -5 373 445 | 30 691 343 | |
| 2015-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -75 000 | 46 736 | -61,61 | ||||
| 2015-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -25 000 | 20 295 | -55,19 | ||||
| 2015-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -13 312 | 64 130 | -17,19 | 567,63 | -7 556 291 | 36 402 112 | |
| 2015-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -935 | 77 442 | -1,19 | 567,63 | -530 734 | 43 958 402 | |
| 2015-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 25 000 | 78 377 | 46,84 | 21,25 | 531 250 | 1 665 511 | |
| 2015-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -39 605 | 53 377 | -42,59 | 567,63 | -22 480 986 | 30 298 387 | |
| 2015-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -4 047 | 92 982 | -4,17 | 567,63 | -2 297 199 | 52 779 373 | |
| 2015-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 75 000 | 97 029 | 340,46 | 30,63 | 2 297 250 | 2 971 998 | |
| 2015-11-09 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | -1 000 | 16 405 | -5,75 | ||||
| 2014-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 80 750 | 80 750 | |||||
| 2014-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 75 000 | 123 079 | 155,99 | ||||
| 2014-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | -3 264 | 0 | -100,00 | ||||
| 2014-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 264 | 6 541 | 99,60 | 30,63 | 99 976 | 200 351 | |
| 2014-11-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -413 | 3 277 | -11,19 | 410,10 | -169 371 | 1 343 898 | |
| 2014-11-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 787 | 3 690 | -32,63 | 409,71 | -732 152 | 1 511 830 | |
| 2014-11-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -3 107 | 5 477 | -36,20 | 415,16 | -1 289 902 | 2 273 831 | |
| 2014-11-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -16 757 | 0 | -100,00 | ||||
| 2014-11-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | -250 | 18 584 | -1,33 | ||||
| 2014-11-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -6 703 | 18 834 | -26,25 | 406,93 | -2 727 652 | 7 664 120 | |
| 2014-11-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -4 747 | 25 537 | -15,67 | 406,93 | -1 931 697 | 10 391 771 | |
| 2014-11-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 16 757 | 30 284 | 123,88 | 115,29 | 1 931 915 | 3 491 442 | |
| 2014-08-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -200 | 13 527 | -1,46 | 341,27 | -68 254 | 4 616 359 | |
| 2014-08-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -9 829 | 13 727 | -41,73 | 340,04 | -3 342 253 | 4 667 729 | |
| 2014-08-11 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 617 | 23 556 | -6,42 | 339,33 | -548 697 | 7 993 257 | |
| 2014-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -200 | 25 173 | -0,79 | 341,00 | -68 200 | 8 583 993 | |
| 2014-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 900 | 25 373 | -6,97 | 340,60 | -647 140 | 8 642 044 | |
| 2014-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -117 | 27 273 | -0,43 | 341,03 | -39 901 | 9 300 911 | |
| 2014-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -624 | 27 390 | -2,23 | 340,39 | -212 403 | 9 323 282 | |
| 2014-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -35 000 | 45 295 | -43,59 | ||||
| 2014-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -18 301 | 28 014 | -39,51 | 336,11 | -6 151 149 | 9 415 786 | |
| 2014-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -2 212 | 46 315 | -4,56 | 336,11 | -743 475 | 15 566 935 | |
| 2014-08-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 35 000 | 48 527 | 258,74 | 21,25 | 743 750 | 1 031 199 | |
| 2014-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 640 | 24 391 | -6,30 | 321,17 | -526 719 | 7 833 657 | |
| 2014-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -3 575 | 26 031 | -12,08 | 320,60 | -1 146 145 | 8 345 539 | |
| 2014-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -3 819 | 29 606 | -11,43 | 319,47 | -1 220 056 | 9 458 229 | |
| 2014-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -6 418 | 33 425 | -16,11 | 318,51 | -2 044 197 | 10 646 197 | |
| 2014-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -5 360 | 39 843 | -11,86 | 317,58 | -1 702 229 | 12 653 340 | |
| 2014-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 800 | 45 203 | -3,83 | 316,55 | -569 790 | 14 309 010 | |
| 2014-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -40 000 | 80 295 | -33,25 | ||||
| 2014-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -6 548 | 0 | -100,00 | ||||
| 2014-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -8 000 | 6 548 | -54,99 | ||||
| 2014-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -3 465 | 47 003 | -6,87 | 324,44 | -1 124 185 | 15 249 653 | |
| 2014-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -339 | 50 468 | -0,67 | 324,44 | -109 985 | 16 373 838 | |
| 2014-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 548 | 50 807 | 14,79 | 16,80 | 110 006 | 853 558 | |
| 2014-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -4 234 | 44 259 | -8,73 | 324,44 | -1 373 679 | 14 359 390 | |
| 2014-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -414 | 48 493 | -0,85 | 324,44 | -134 318 | 15 733 069 | |
| 2014-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 8 000 | 48 907 | 19,56 | 16,80 | 134 400 | 821 638 | |
| 2014-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -20 865 | 40 907 | -33,78 | 324,44 | -6 769 441 | 13 271 867 | |
| 2014-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -2 619 | 61 772 | -4,07 | 324,44 | -849 708 | 20 041 308 | |
| 2014-02-13 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 40 000 | 64 391 | 163,99 | 21,25 | 850 000 | 1 368 309 | |
| 2013-12-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | -4 705 | 0 | -100,00 | ||||
| 2013-12-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 705 | 24 391 | 23,90 | 21,25 | 99 981 | 518 309 | |
| 2013-12-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | -9 302 | 19 686 | -32,09 | 272,73 | -2 536 934 | 5 368 963 |
| 2013-12-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 95 000 | 95 000 | |||||
| 2013-12-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 75 000 | 121 736 | 160,48 | ||||
| 2013-05-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -9 660 | 48 988 | -16,47 | 277,12 | -2 676 979 | 13 575 555 | |
| 2013-05-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -13 378 | 58 648 | -18,57 | 276,71 | -3 701 826 | 16 228 488 | |
| 2013-05-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 4 527 | 4 527 | |||||
| 2013-05-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -55 438 | 0 | -100,00 | ||||
| 2013-05-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -27 873 | 72 026 | -27,90 | 268,40 | -7 481 113 | 19 331 778 | |
| 2013-05-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -4 527 | 99 899 | -4,34 | 268,40 | -1 215 047 | 26 812 892 | |
| 2013-05-14 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 55 438 | 104 426 | 113,17 | 21,92 | 1 215 201 | 2 289 018 | |
| 2012-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | -5 952 | 0 | -100,00 | ||||
| 2012-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 952 | 48 988 | 13,83 | 16,80 | 99 994 | 822 998 | |
| 2012-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 112 500 | 112 500 | |||||
| 2012-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 75 000 | 120 295 | 165,58 | ||||
| 2012-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | -8 386 | 43 036 | -16,31 | 179,13 | -1 502 184 | 7 709 039 |
| 2012-12-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | -4 562 | 0 | -100,00 | ||||
| 2012-12-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | -4 921 | 0 | -100,00 | ||||
| 2012-12-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 921 | 51 422 | 10,58 | 20,32 | 99 995 | 1 044 895 | |
| 2012-12-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 562 | 46 501 | 10,88 | 21,92 | 99 999 | 1 019 302 | |
| 2012-12-03 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -17 182 | 41 939 | -29,06 | 181,01 | -3 110 114 | 7 591 378 | |
| 2012-11-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -2 000 | 59 121 | -3,27 | 175,49 | -350 980 | 10 375 144 | |
| 2012-11-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -13 157 | 61 121 | -17,71 | 174,47 | -2 295 502 | 10 663 781 | |
| 2012-11-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -9 200 | 74 278 | -11,02 | 173,80 | -1 598 960 | 12 909 516 | |
| 2012-11-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -37 500 | 14 548 | -72,05 | ||||
| 2012-11-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17 000 | 52 048 | -24,62 | ||||
| 2012-11-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -16 973 | 83 478 | -16,90 | 167,17 | -2 837 376 | 13 955 017 | |
| 2012-11-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -3 768 | 100 451 | -3,62 | 167,17 | -629 897 | 16 792 394 | |
| 2012-11-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 37 500 | 104 219 | 56,21 | 16,80 | 630 000 | 1 750 879 | |
| 2012-11-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -7 694 | 66 719 | -10,34 | 167,17 | -1 286 206 | 11 153 415 | |
| 2012-11-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -1 708 | 74 413 | -2,24 | 167,17 | -285 526 | 12 439 621 | |
| 2012-11-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 17 000 | 76 121 | 28,75 | 16,80 | 285 600 | 1 278 833 | |
| 2012-08-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -5 998 | 59 121 | -9,21 | 146,41 | -878 167 | 8 655 906 | |
| 2012-08-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -9 386 | 65 119 | -12,60 | 145,44 | -1 365 100 | 9 470 907 | |
| 2012-08-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 500 | 74 505 | -1,97 | 144,92 | -217 380 | 10 797 265 | |
| 2012-08-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 6 017 | 6 017 | |||||
| 2012-08-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -40 000 | 55 438 | -41,91 | ||||
| 2012-08-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -17 099 | 76 005 | -18,37 | 145,70 | -2 491 324 | 11 073 928 | |
| 2012-08-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -6 017 | 93 104 | -6,07 | 145,70 | -876 677 | 13 565 253 | |
| 2012-08-30 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 40 000 | 99 121 | 67,66 | 21,92 | 876 800 | 2 172 732 | |
| 2012-06-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -600 | 59 121 | -1,00 | 118,10 | -70 860 | 6 982 190 |
| 2012-06-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -4 383 | 59 721 | -6,84 | 117,34 | -514 301 | 7 007 662 |
| 2012-06-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -9 080 | 64 104 | -12,41 | 116,41 | -1 057 003 | 7 462 347 |
| 2012-06-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -24 848 | 73 184 | -25,35 | 115,60 | -2 872 429 | 8 460 070 |
| 2012-06-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | X | 16 757 | 16 757 | ||||
| 2012-06-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -95 079 | 0 | -100,00 | |||
| 2012-06-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | -39 411 | 98 032 | -28,67 | 115,29 | -4 543 694 | 11 302 109 |
| 2012-06-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | -16 757 | 137 443 | -10,87 | 115,29 | -1 931 915 | 15 845 803 |
| 2012-06-20 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 95 079 | 154 200 | 160,82 | 20,32 | 1 932 005 | 3 133 344 |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -2 025 | 59 121 | -3,31 | 108,09 | -218 882 | 6 390 389 | |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -19 057 | 61 146 | -23,76 | 107,79 | -2 054 154 | 6 590 927 | |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -50 000 | 69 048 | -42,00 | ||||
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -600 | 80 203 | -0,74 | 113,47 | -68 082 | 9 100 634 | |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -1 115 | 80 803 | -1,36 | 112,10 | -124 992 | 9 058 016 | |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -600 | 81 918 | -0,73 | 111,91 | -67 146 | 9 167 443 | |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -17 694 | 82 518 | -17,66 | 110,35 | -1 952 533 | 9 105 861 | |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -8 510 | 100 212 | -7,83 | 109,61 | -932 781 | 10 984 237 | |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -2 350 | 108 722 | -2,12 | 108,60 | -255 210 | 11 807 209 | |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | -333 | 111 072 | -0,30 | 107,83 | -35 907 | 11 976 894 | |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -21 352 | 111 405 | -16,08 | 111,01 | -2 370 286 | 12 367 069 | |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -7 566 | 132 757 | -5,39 | 111,01 | -839 902 | 14 737 355 | |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 50 000 | 140 323 | 55,36 | 16,80 | 840 000 | 2 357 426 | |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -3 432 | 0 | -100,00 | ||||
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | -63 234 | 3 432 | -94,85 | ||||
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -1 597 | 90 323 | -1,74 | 113,35 | -181 020 | 10 238 112 | |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -257 | 91 920 | -0,28 | 113,35 | -29 131 | 10 419 132 | |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 432 | 92 177 | 3,87 | 8,50 | 29 172 | 783 504 | |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -28 869 | 88 745 | -24,55 | 113,35 | -3 272 301 | 10 059 246 | |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | -4 741 | 117 614 | -3,87 | 113,35 | -537 392 | 13 331 547 | |
| 2012-02-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 63 234 | 122 355 | 106,96 | 8,50 | 537 489 | 1 040 018 | |
| 2007-04-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -780 | 4 297 | -15,36 | 25,75 | -20 085 | 110 648 |
| 2007-04-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 083 | 5 077 | -29,09 | 25,65 | -53 429 | 130 225 |
| 2007-04-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -694 | 7 160 | -8,84 | 25,62 | -17 780 | 183 439 |
| 2007-04-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -70 | 7 854 | -0,88 | 25,61 | -1 793 | 201 141 |
| 2007-04-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 972 | 7 924 | -42,98 | 25,60 | -152 883 | 202 854 |
| 2007-04-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -70 | 13 896 | -0,50 | 25,57 | -1 790 | 355 321 |
| 2007-04-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -139 | 13 966 | -0,99 | 25,56 | -3 553 | 356 971 |
| 2007-04-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -486 | 14 105 | -3,33 | 25,55 | -12 417 | 360 383 |
| 2007-04-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -152 | 14 591 | -1,03 | 25,50 | -3 876 | 372 070 |
| 2007-04-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 | 14 743 | -0,01 | 25,49 | -25 | 375 799 |
| 2007-04-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -208 | 14 744 | -1,39 | 25,45 | -5 294 | 375 235 |
| 2007-04-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -69 | 14 952 | -0,46 | 25,44 | -1 755 | 380 379 |
| 2007-04-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -264 | 15 021 | -1,73 | 25,41 | -6 708 | 381 684 |
| 2007-04-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | -25 000 | 25 000 | -50,00 | |||
| 2007-04-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | -5 609 | 15 285 | -26,85 | 26,09 | -146 339 | 398 786 |
| 2007-04-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | -8 403 | 20 894 | -28,68 | 26,09 | -219 234 | 545 124 |
| 2007-04-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 25 000 | 29 297 | 581,80 | 8,77 | 219 250 | 256 935 |
| 2004-04-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | -250 | 15 482 | -1,59 | 19,65 | -4 912 | 304 221 | |
| 2003-12-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 92 308 | 92 308 | |||||
| 2003-12-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
A - Award | 7 692 | 7 692 | |||||
| 2003-12-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
A - Award | 6 977 | 17 441 | 66,68 |